Mostrar el registro sencillo del ítem

dc.contributor.author
Croci Russo, Diego Omar  
dc.contributor.author
Salatino, Mariana  
dc.date.available
2017-03-17T15:05:02Z  
dc.date.issued
2011-04  
dc.identifier.citation
Croci Russo, Diego Omar; Salatino, Mariana; Tumor immune escape mechanisms that operate during metastasis; Bentham Science Publishers; Current Pharmaceutical Biotechnology; 12; 11; 4-2011; 1923-1936  
dc.identifier.issn
1389-2010  
dc.identifier.uri
http://hdl.handle.net/11336/14011  
dc.description.abstract
Immune cells actively influence, among other factors, each step of tumor development determining the chance of a cancer cell to survive in a threaten microenvironment. Antitumor immune-mediated mechanisms are activated as soon as the first cancer cell is detected and operate both during primary tumor formation and during metastasis. However, when both innate and adaptive immunity becomes impaired, tumor development occurs. In this sense, compelling evidences indicate that tumor cells employ mechanisms that circumvent or thwart the immune response to enhance their own growth. These mechanisms include the secretion of immunosuppressive factors and the induction of distinct regulatory lymphoid or myeloid cells and, as occur with the immune response, they operate both during primary tumor formation and metastasis. Interestingly, cellular and molecular mechanisms of the immune response are important components of the tumor microenvironment and have the ability to promote or suppress tumor progression depending of the context of each cell interaction. In that sense, researchers are focusing their attention in the study of the influence of the tumor microenvironment in tumor growth and metastasis to better understand cancer biology and to formulate novel therapeutic approach. This review will focus on the present knowledge about interaction between immune cells and tumors in the context of metastasis, discussing the participation of different components of innate and adaptive immune response in the process of metastasis formation and dissemination.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Bentham Science Publishers  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Metastasis  
dc.subject
Galectins  
dc.subject
Antitumor Immunity  
dc.subject
Cancer  
dc.subject
Mieloyd Cells  
dc.subject.classification
Bioquímica y Biología Molecular  
dc.subject.classification
Ciencias Biológicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.subject.classification
Inmunología  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Tumor immune escape mechanisms that operate during metastasis  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2017-03-08T15:18:38Z  
dc.identifier.eissn
1873-4316  
dc.journal.volume
12  
dc.journal.number
11  
dc.journal.pagination
1923-1936  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Hilversum  
dc.description.fil
Fil: Croci Russo, Diego Omar. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i); Argentina  
dc.description.fil
Fil: Salatino, Mariana. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i); Argentina  
dc.journal.title
Current Pharmaceutical Biotechnology  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.eurekaselect.com/75846/article  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.2174/138920111798376987